接受上皮性卵巢癌化疗的多种族人群中的非计划住院
本研究回顾性分析了2005至2016年在本机构接受化疗的217例新诊断上皮性卵巢癌患者,发现87例(40%)化疗后发生非计划入院,其中辅助化疗64例(74%)、新辅助化疗23例(26%),30例(14%)有多次入院。体重指数和高血压可预测再入院(p<0.05);多次入院者中,种族和阿司匹林使用可预测再入院(p<0.05)。化疗后非计划入院患者与未入院患者相比,无病生存(p=0.01)和总生存(p=0.004)存在显著差异。
要点
- 化疗后非计划入院率为40%(87/217),高于既往文献报告的10-35%。
- 体重指数和高血压可预测再入院(p<0.05)。
- 多次入院者中,种族和阿司匹林使用可预测再入院(p<0.05)。
核心结论
- 本 racially diverse 患者群体的再入院率高于既往文献报告。
- 识别有再入院风险的患者可能对化疗决策和资源分配(包括患者护理导航员)有作用。
研究设计与样本
- 经IRB批准后,回顾性提取2005至2016年在本机构接受化疗的所有新诊断上皮性卵巢癌患者的临床病理和治疗数据。
- 共217例可评估患者,使用Stata进行双侧统计分析和Cox回归分析。
主要发现
- 87例(40%)化疗后发生非计划入院,其中辅助化疗64例(74%)、新辅助化疗23例(26%)。
- 30例(14%)有超过1次入院,总住院天数为1314天,中位再入院时间为3天。
- 体重指数和高血压可预测再入院(p<0.05)。
- 多次入院者与单次入院者相比,种族和阿司匹林使用可预测再入院(p<0.05)。
- 多次入院者中,自报种族和族裔为西班牙裔12例(40%)、白人8例(27%)、黑人8例(27%)、其他2例(7%)。
临床怎么用
- 作者认为,识别有再入院风险的患者可能对化疗决策和资源分配(包括患者护理导航员)有作用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Unplanned hospital admission following chemotherapy is a measure of quality cancer care. Large retrospective datasets have shown admission rates of 10-35% for women with ovarian cancer receiving chemotherapy. We sought to evaluate the prevalence and associated risk factors for hospital admission following chemotherapy in our racially diverse urban population. METHODS: After IRB approval, clinicopathologic and treatment data were abstracted from all patients with newly diagnosed epithelial ovarian cancer who received chemotherapy at our institution from 2005 to 2016. Two-sided statistical analyses and Cox regression analysis were performed using Stata. RESULTS: Of 217 evaluable patients, 87 (40%) had unplanned admissions following chemotherapy: adjuvant 64 (74%) and neoadjuvant 23(26%). Thirty (14%) had more than one admission. In total, there were 1314 days of hospitalization. The median readmission duration was 3 days. Body mass index and hypertension were predictive of readmission (p < 0.05). When comparing those readmitted more than once to those admitted once, both race and aspirin use were predictive of readmission (p < 0.05). Of those admitted more than once the self-identified race and ethnicity was 12 (40%) Hispanic, 8 (27%) White, 8 (27%) Black and 2 (7%) other. There was a significant difference in disease free (p = 0.01) and overall survival (p = 0.004) for patients with unplanned admission after chemotherapy as compared to those without admission. CONCLUSIONS: Readmission rates in our racially diverse patient population were higher than previously reported in the literature. Identifying patients at risk of readmission may play a role in chemotherapy decision-making, and resource allocation including patient care navigators.
引用
- Dioun S, Jorgensen JR, Miller EM, et al. Unplanned hospitalizations in a racially and ethnically diverse population of women receiving chemotherapy for epithelial ovarian cancer. Gynecol Oncol. 2018. PMID: 30149897. doi:10.1016/j.ygyno.2018.08.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。